— Know what they know.
Not Investment Advice

BLEVF OTC

Beleave Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -90.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 49 · $566 mcap · 547M float · 0.0029% daily turnover

Cash Flow Trends

Operating Cash Flow
-$9M -61.1% ▼
Capital Expenditures
$8M -366.1% ▼
Free Cash Flow
-$17M -128.9% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$11M -215.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2014FY2015FY2016FY2017FY2018
— Operating Activities —
Net Income-$510K-$3M-$9M-$13M-$34M
Depreciation & Amort.$0$0$0$327K$3M
Stock-Based Comp.$0$750K$6M$6M$0
Change in Working Capital$138K$412K$1M-$2M-$17K
Other Non-Cash Items$0$1M$47K$2M$11M
Operating Cash Flow-$372K-$366K-$1M-$6M-$9M
— Investing Activities —
Capital Expenditures-$862K-$39K-$1M-$2M-$8M
Acquisitions (Net)$0$0$0$0$70K
Investment Purchases$0$0$0$0-$900K
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0-$291K
Investing Cash Flow-$862K-$39K-$1M-$2M-$9M
— Financing Activities —
Net Debt Issuance$0$0$0$5M-$300K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$358K$0-$38K$3M-$6M
Financing Cash Flow$358K$399K$4M$18M$7M
Net Change in Cash-$876K-$409$2M$10M-$11M
Cash End of Period$231K$231K$2M$12M$538K
Free Cash Flow-$1M-$405K-$2M-$8M-$17M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms